Experimental treatment for Niemann-Pick disease appears safe
Por um escritor misterioso
Descrição
An experimental drug has appeared to slow the progression of Niemann-Pick disease the drug 2-hydroxypropyl-beta-cyclodextrin is being tested
Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS - The Lancet Child & Adolescent Health
Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro: Molecular Therapy - Nucleic Acids
IJMS, Free Full-Text
Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB
Niemann-Pick Disease, A Pipeline Analysis Report 2018, Technavio
Experimental treatment for Niemann-Pick disease appears safe
Dermatologic Manifestations of Niemann-Pick Disease: Background, Pathophysiology, Etiology
The Neuropsychiatry of Niemann-Pick Type C Disease in Adulthood
Niemann-Pick Disease, Type a disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
Understanding the phenotypic variability in Niemann-Pick disease type C (NPC): a need for precision medicine
Emerging Startups Take Aim at Lysosomal Storage Disorders
de
por adulto (o preço varia de acordo com o tamanho do grupo)
